Google has set up a venture capital fund that will be used to invest in a range of industries, including biotech and healthcare, and is willing to plough tens of millions of dollars into individual companies.
Administrators are now trying to sell Jaycare, a UK custom
manufacturer and supplier of rigid plastic packaging, medical
devices and technical componentry to the pharma and healthcare
industries, which has gone bust.
According to new data, venture capital funding is on a downswing
with a demand for acquisitions shifting in the pharmaceutical
sector. The news could signal a trend towards the acquisition of
compounds, rights, licenses and product...
A new survey has revealed that venture capital investment in health
care ventures rarely goes beyond the money bestowed, and claims
that VCs add value through their expertise are rarely if ever
Senior executives at LGC, a UK-headquartered provider of
pharmaceutical reference materials and analytical and diagnostic
services, are gearing up for a secondary buyout that will help it
to accelerate its expansion into international...
Abingworth Management, a UK venture capital group, has raised a
$350 million investment vehicle in a move that lends further weight
to suggestions that the funding crisis hitting the biotechnology
sector may be nearing its end.
Venture capital investments in biotechnology and medical device
companies combined to total $4.7 billion (€4.4bn) in 2002, or 22
per cent of all investing, representing the highest proportion in
seven years, according to the MoneyTree...